References
- Guttmacher Institute. Contraceptive Use in the United States. New York: Guttmacher Institute; 2014 [cited 2014 Aug 11]. Available from: http://www.guttmacher.org/pubs/fb_contr_use.pdf.
- United Nations, Department of Economic and Social Affairs, Population Division. Trends in Contraceptive Use Worldwide 2015.
- Dinh A, Sriprasert I, Williams AR, et al. A review of the endometrial histologic effects of progestins and progesterone receptor modulators in reproductive age women. Contraception. 2015;91:360–367.
- Hatcher RA, Trussell J, Nelson AL, Contraceptive technology. New York: Ardent Media; 2008.
- McCann MF, Potter LS. Progestin-only oral contraception: a comprehensive review: II. Mode of action. Contraception. 1994;50:S13–S21.
- Moghissi KS, Syner FN, Evans TN. A composite picture of the menstrual cycle. Am J Obstet Gynecol. 1972;114:405–418.
- WHO | WHO laboratory manual for the examination and processing of human semen [Internet]. WHO. [cited 2016 Feb 11]. Available from: http://www.who.int/reproductivehealth/publications/infertility/9789241547789/en/.
- Han L, Padua E, Edelman A, et al. Appraising cervical mucus: a new approach to evaluating contraceptives. Eur J Contracept Reprod Health Care. 2018;23:78–83.
- Jonsson B, Landgren B-M, Eneroth P. Effects of various iuds on the composition of cervical mucus. Contraception. 1991;43:447–458.
- Su H, Yi Y, Wei T, et al. Detection of ovulation, a review of currently available methods. Bioeng Transl Med. 2017;2:238–246.
- Abbvie. Lupron (leuprolide acetate for depot administration) prescribing information [Internet.]. [cited 2015 Jan 24]. Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/019732s040,020517s035lbl.pdf.
- Torgrimson BN, Meendering JR, Kaplan PF, et al. Depot-medroxyprogesterone acetate and endothelial function before and after acute oral, vaginal, and transdermal estradiol treatment. Hypertension. 2011;57:819–824.
- Stricker R, Eberhart R, Chevailler M-C, et al. Establishment of detailed reference values for luteinizing hormone, follicle stimulating hormone, estradiol, and progesterone during different phases of the menstrual cycle on the Abbott ARCHITECT analyzer. Clin Chem Lab Med CCLM FESCC. 2006;44:883–887.
- Soules MR, McLachlan RI, Ek M, et al. Luteal phase deficiency: characterization of reproductive hormones over the menstrual cycle. J Clin Endocrinol Metab. 1989;69:804–812.
- Novartis Pharmaceuticals. Vivelle-Dot Full Prescribing Information [Internet]. 2014 [cited 2014 Nov 9]. Available from: https://www.pharma.us.novartis.com/product/pi/pdf/Vivelle_DOT.pdf.
- DailyMed - PROMETRIUM - progesterone capsule [Internet]. [cited 2019 Mar 6]. Available from: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cf73c385-5173-4b54-af23-069581c5d560.
- Janssen Pharmaceuticals. Ortho Micronor Prescribing Information. Janssen Pharmaceuticals Inc. 2001; [cited 2014 Nov 21]. Available from: https://www.janssen.com/canada/sites/www_janssen_com_canada/files/prod_files/live/micronor_cpm.pdf.
- CooperSurgical. Unimar Aspirette Device Description [Internet]. [cited 2014 Sep 3]. Available from: www.coopersurgical.com/…/36024-DFU.pdf.
- Edelman AB, Cherala G, Blue SW, et al. Impact of obesity on the pharmacokinetics of levonorgestrel-based emergency contraception: single and double dosing. Contraception. 2016;94:52–57.
- Blue SW, Winchell AJ, Kaucher AV, et al. Simultaneous quantitation of multiple contraceptive hormones in human serum by LC–MS/MS. Contraception. 2018;97:363–369.
- Han L, Taub R, Jensen JT. Cervical mucus and contraception: what we know and what we don't. Contraception. 2017;96:310–321.
- Cox. The pre-coital use of mini-dosage progestagens. J Reprod Fertil Suppl. 1968;6:167–172.
- Atrio J, Stek A, Vora H, et al. The effect of protease inhibitors on the cervical mucus of HIV-positive women taking norethindrone contraception. Eur J Contracept Reprod Health Care. 2015;20:149–153.
- Prasad KVS, Rao BSN, Sivakumar B, et al. Pharmacokinetics of norethindrone in Indian women. Contraception. 1979;20:77–90.
- Task Force on Oral Contraceptives, Sheth A, Jain U, et al. A randomized, double-blind study of two combined and two progestogen-only oral contraceptives. Contraception. 1982;25:243–252.
- Back DJ, Orme ML. Pharmacokinetic drug interactions with oral contraceptives. Clin Pharmacokinet. 1990;18:472–484.
- Ng J, Chwalisz K, Carter DC, et al. Dose-dependent suppression of gonadotropins and ovarian hormones by elagolix in healthy premenopausal women. J Clin Endocrinol Metab. 2017;102:1683–1691.